A detailed history of Allianz Asset Management Gmb H transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 48,947 shares of RDY stock, worth $752,315. This represents 0.01% of its overall portfolio holdings.

Number of Shares
48,947
Previous 51,769 5.45%
Holding current value
$752,315
Previous $3.94 Million 1.42%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$75.41 - $84.21 $212,807 - $237,640
-2,822 Reduced 5.45%
48,947 $3.89 Million
Q2 2024

Aug 13, 2024

BUY
$68.26 - $76.19 $136,997 - $152,913
2,007 Added 4.03%
51,769 $3.94 Million
Q1 2024

May 13, 2024

BUY
$67.36 - $77.59 $346,567 - $399,200
5,145 Added 11.53%
49,762 $3.65 Million
Q4 2023

Feb 12, 2024

SELL
$64.27 - $69.9 $157,011 - $170,765
-2,443 Reduced 5.19%
44,617 $3.1 Million
Q3 2023

Nov 13, 2023

BUY
$61.9 - $72.77 $206,498 - $242,760
3,336 Added 7.63%
47,060 $3.15 Million
Q2 2023

Aug 11, 2023

BUY
$53.34 - $63.11 $1.52 Million - $1.8 Million
28,557 Added 188.28%
43,724 $2.76 Million
Q1 2023

May 11, 2023

BUY
$51.63 - $56.93 $783,072 - $863,457
15,167 New
15,167 $863,000
Q4 2021

Feb 11, 2022

SELL
$59.5 - $67.25 $171,122 - $193,411
-2,876 Reduced 43.9%
3,675 $240,000
Q3 2021

Nov 10, 2021

BUY
$60.19 - $75.29 $10,533 - $13,175
175 Added 2.74%
6,551 $427,000
Q2 2021

Aug 16, 2021

BUY
$62.12 - $74.2 $7,516 - $8,978
121 Added 1.93%
6,376 $469,000
Q1 2021

May 13, 2021

SELL
$57.98 - $73.08 $310,888 - $391,854
-5,362 Reduced 46.16%
6,255 $384,000
Q4 2020

Feb 16, 2021

SELL
$62.61 - $71.29 $126,346 - $143,863
-2,018 Reduced 14.8%
11,617 $828,000
Q3 2020

Nov 13, 2020

SELL
$51.39 - $72.41 $235,725 - $332,144
-4,587 Reduced 25.17%
13,635 $949,000
Q2 2020

Aug 14, 2020

BUY
$39.55 - $54.65 $104,293 - $144,112
2,637 Added 16.92%
18,222 $966,000
Q1 2020

May 14, 2020

BUY
$34.75 - $45.85 $541,578 - $714,572
15,585 New
15,585 $629,000
Q3 2019

Nov 13, 2019

SELL
$34.82 - $39.26 $226,330 - $255,190
-6,500 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$36.05 - $42.76 $603,188 - $715,460
-16,732 Reduced 72.02%
6,500 $244,000
Q4 2018

Feb 14, 2019

SELL
$31.89 - $38.44 $51,024 - $61,504
-1,600 Reduced 6.44%
23,232 $876,000
Q3 2018

Nov 13, 2018

BUY
$29.25 - $36.73 $266,175 - $334,243
9,100 Added 57.84%
24,832 $859,000
Q2 2018

Aug 13, 2018

BUY
$28.49 - $35.06 $34,188 - $42,072
1,200 Added 8.26%
15,732 $507,000
Q3 2017

Nov 13, 2017

SELL
$30.11 - $37.72 $707,314 - $886,080
-23,491 Reduced 61.78%
14,532 $519,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,411 Added 3.85%
38,023 $1.6 Million
Q1 2017

Apr 17, 2019

BUY
N/A
10,800 Added 41.84%
36,612 $1.47 Million
Q4 2016

Apr 17, 2019

BUY
N/A
5,368 Added 26.26%
25,812 $1.17 Million
Q3 2016

Apr 17, 2019

BUY
N/A
20,444
20,444 $948,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.55B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.